Pharmacological neuroprotecion during cardiac surgery

Asian Cardiovascular and Thoracic Annals

Volumn 15, Issue 2, 2007, Pages 167-177

  Kadoi, Yuji ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; APROTININ; BARBITURIC ACID DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; CORTICOSTEROID; DEFEROXAMINE; DELTA OPIATE RECEPTOR; DEXMEDETOMIDINE; FENTANYL; FREE RADICAL; GANGLIOSIDE GM1; GLUCOCORTICOID; ISOFLURANE; MANNITOL; MIVAZEROL; MONOSIALOGANGLIOSIDE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NIMODIPINE; NORPHENAZONE; OPIATE AGONIST; PLACEBO; PROPOFOL; PROSTACYCLIN; REMACEMIDE; THIOPENTAL; UNINDEXED DRUG; BENZODIAZEPINE RECEPTOR AFFECTING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROPROTECTIVE AGENT; SCAVENGER;

BLEEDING; BRAIN ATROPHY; BRAIN BLOOD FLOW; BRAIN INJURY; BRAIN ISCHEMIA; CLINICAL TRIAL; COGNITIVE DEFECT; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DRUG EFFECT; DRUG EFFICACY; DRUG FATALITY; DRUG MECHANISM; DRUG SAFETY; HEAD INJURY; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART MUSCLE ISCHEMIA; HEART SURGERY; HEART VALVE SURGERY; HUMAN; ISCHEMIC PRECONDITIONING; META ANALYSIS; NEUROLOGIC DISEASE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OUTCOME ASSESSMENT; OXYGEN SATURATION; PATHOGENESIS; PERIOPERATIVE PERIOD; REPERFUSION INJURY; REVIEW; RISK REDUCTION; SURGICAL RISK; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VALVULAR HEART DISEASE; CARDIOPULMONARY BYPASS; DRUG ANTAGONISM; MENTAL DISEASE;

CALCIUM CHANNEL BLOCKERS; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; FREE RADICAL SCAVENGERS; GABA MODULATORS; HUMANS; ISCHEMIC PRECONDITIONING; MENTAL DISORDERS; NERVOUS SYSTEM DISEASES; NEUROPROTECTIVE AGENTS; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 34248381340     PISSN: 02184923     EISSN: None     Source Type: Journal    
DOI: 10.1177/021849230701500220     Document Type: Review

References (79)

1. The United Kingdom Cardiac Surgical Register, 1977-2000. http://www.scts.org/doc/2104.
2. Arrowsmith JE, Grocott HP, Reves JG, Newman MF. Central nervous system complications of cardiac surgery. Brit J Anaesth 2000;84:378-93.
3. Hogue CW Jr, Murphy SF, Schechtman KB, Davila-Roman VG. Risk factors for early or delayed stroke after cardiac surgery. Circulation 1999;100:642-7.
4. Hindman BJ, Todd MM. Improving neurologic outcome after cardiac surgery. Anesthesiology 1999;90:1243-7.
5. van Dijk D, Keizer AM, Diephuis JC, Durand C, Vos LJ, Hijman R. Neurocognitive dysfunction after coronary artery bypass surgery: a systematic review. J Thorac Cardiovasc Surg 2000;120:632-9.
6. Michenfelder JD. The interdependency of cerebral functional and metabolic effects following massive doses of thiopental in the dog. Anesthesiology 1974;41:231-6.
7. Smith DS, Rehncrona S, Siesjo BK. Inhibitory effects of different barbiturates on lipid peroxidation in brain tissue in vitro. Comparison with the effects of promethazine and chlorpromazine. Anesthesiology 1980;53:186-94.
8. Shiu GK, Nemoto EM. Barbiturate attenuation of brain free fatty acid liberation during global ischemia. J Neurochem 1981;37:1448-56.
9. Nussmeier NA, Arlund C, Slogoff S. Neuropsychiatric complications after cardiopulmonary bypass: cerebral protection by a barbiturate. Anesthesiology 1986;64:165-70.
10. Zaidan JR, Klochany A, Martin WM, Ziegler JS, Harless DM, Andrews RB. Effect of thiopental on neurologic outcome following coronary artery bypass grafting. Anesthesiology 1991;74:406-11.
11. Pascoe EA, Hudson RJ, Anderson BA, Kassum DA, Shanks A, Rosenbloom M, Thomson IR. High-dose thiopentone for open-chamber cardiac surgery: a retrospective review. Can J Anaesth 1996;43:575-9.
12. Ito H, Watanabe Y, Isshiki A, Uchino H. Neuroprotective properties of propofol and midazolam, but not pentobarbital, on neuronal damage induced by forebrain ischemia, based on the GABA-A receptors. Acta Anaesthesiol Scand 1999;43:153-62.
13. Kahn RA, Panah M, Weinberger J. Modulation of ischemic excitatory neurotransmitter and gamma-aminobutyric acid release during global temporary cerebral ischemia by selective neuronal nitric oxide synthase inhibition. Anesth Analg 1997;84:997-1003.
14. Kahn RA, Panah M, Kiffel S, Weinberger J. Modulation of ischemic excitatory neurotransmitter and gamma-aminobutyric acid release during global temporary cerebral ischemia by local nitric oxide synthase inhibition. Anesth Analg 1997;84:1004-10.
15. Sagara Y, Hendler S, Khoh-Reiter S, Gillenwater G, Carlo D, Schubert D, et al. Propofol hemisuccinate protects neuronal cells from oxidative injury. J Neurochem 1999;73:2524-30.
16. Roach GW, Newman MF, Murkin JM, Martzke J, Ruskin A, Li J, et al. Ineffectiveness of burst suppression therapy in mitigating perioperative cerebrovascular dysfunction. Multicenter Study of Perioperative Ischemia (McSPI) Research Group. Anesthesiology 1999;90:1255-64.
17. Kadoi Y, Saito S, Kunimoto F, Goto F, Fujita N. Comparative effects of propofol versus fentanyl on cerebral oxygenation state during normothermic cardiopulmonary bypass and postoperative cognitive dysfunction. Ann Thorac Surg 2003;75:840-6.
18. Smith WS. Pathophysiology of focal cerebral ischemia: a therapeutic perspective. J Vasc Interv Radiol 2004;15(1 Pt 2):S3-12.
19. Schaller B, Graf R. Cerebral ischemia and reperfusion: the pathophysiologic concept as a basis for clinical therapy. J Cereb Blood Flow Metab 2004;24:351-71.
20. Pickard JD, Murray GD, Illingworth R, Shaw MD, Teasdale GM, Foy PM, et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ 1989;298:636-42.
21. Forsman M, Olsnes BT, Semb G, Steen PA. Effects of nimodipine on cerebral blood flow and neuropsychological outcome after cardiac surgery. Br J Anaesth 1990;65:514-20.
22. Legault C, Furberg CD, Wagenknecht LE, Rogers AT, Stump DA, Coker L, et al. Nimodipine neuroprotection in cardiac valve replacement: report of an early terminated trial. Stroke 1996;27:593-8.
23. Arrowsmith JE, Harrison MJ, Newman SP, Stygall J, Timberlake N, Pugsley WB. Neuroprotection of the brain during cardiopulmonary bypass: a randomized trial of remacemide during coronary artery bypass in 171 patients. Stroke 1998;29:2357-62.
24. Ikonomidou C, Stefovska V, Turski L. Neuronal death enhanced by N-methyl-D-aspartate antagonists. Proc Natl Acad Sci USA 2000;97:12885-90.
25. Prass K, Ruscher K, Karsch M, Isaev N, Megow D, Priller J, et al. Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro. J Cereb Blood Flow Metab 2002;22:520-5.
26. Menasche P, Pasquier C, Bellucci S, Lorente P, Jaillon P, Piwnica A. Desferrioxamine reduces neutrophil-mediated free radical production during cardiopulmonary bypass in man. J Thorac Cardiovasc Surg 1988;96:582-9.
27. Himmelseher S, Pfenninger E. Neuroprotection in neuroanesthesia: current practices in Germany. Anaesthesist 2000;49:412 9.
28. Luvisotto TL, Auer RN, Sutherland GR. The effect of mannitol on experimental cerebral ischemia, revisited. Neurosurgery 1996;38:131 9.
29. Korenkov AI, Pahnke J, Frei K, Warzok R, Schroeder HW, Frick R, et al. Treatment with nimodipine or mannitol reduces programmed cell death and infarct size following focal cerebral ischemia. Neurosurg Rev 2000;23:145 50.
30. Suzuki K, Kazui T, Terada H, Umemura K, Ikeda Y, Bashar AH, et al. Experimental study on the protective effects of edaravone against ischemic spinal cord injury. J Thorac Cardiovasc Surg 2005;130:1586 92.
31. Fish KJ, Sarnquist FH, van Steennis C, Mitchell RS, Hilberman M, Jamieson SW, et al. A prospective, randomized study of the effects of prostacyclin on platelets and blood loss during coronary bypass operations. J Thorac Cardiovasc Surg 1986;91:436-42.
32. Fish KJ, Helms KN, Samquist FH, van Steennis C, Linet OI, Hilberman M, et al. A prospective, randomized study of the effects of prostacyclin on neuropsychologic dysfunction after coronary artery operation. J Thorac Cardiovasc Surg 1987;93:609-15.
33. del Zoppo GJ, Schmid-Schonbein GW, Mori E, Copeland BR, Chang CM. Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons. Stroke 1991;22:1276-83.
34. Lord RA, Roath OS, Thompson JF, Chant AD, Francis JL. Effect of aprotinin on neutrophil function after major vascular surgery. Br J Surg 1992;79:517-21.
35. Hill GE, Alonso A, Spurzem JR, Stammers AH, Robbins RA. Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans. J Thorac Cardiovasc Surg 1995;110:1658-62.
36. Smith PK, Muhlbaier LH. Aprotinin: safe and effective only with the full-dose regimen. Ann Thorac Surg 1996;62:1575-7.
37. Frumento RJ, O'Malley CM, Bennett-Guerrero E. Stroke after cardiac surgery: a retrospective analysis of the effect of aprotinin dosing regimens. Ann Thorac Surg 2003;75:479-84.
38. Leal-Noval SR, Amaya R, Herruzo A, Hernandez A, Ordonez A, Marin-Niebla A, et al. Effects of a leukocyte depleting arterial line filter on perioperative morbidity in patients undergoing cardiac surgery: a controlled randomized trial. Ann Thorac Surg 2005;80:1394-1400.
39. de Vries AJ, Gu YJ, Post WJ, Vos P, Stokroos I, Lip H, et al. Leucocyte depletion during cardiac surgery: a comparison of different filtration strategies. Perfusion 2003;18:31-8.
40. Whitaker DC, Stygall JA, Newman SP, Harrison MJ. The use of leucocyte-depleting and conventional arterial line filters in cardiac surgery: a systematic review of clinical studies. Perfusion 2001;16:433-46.
41. Tamok A, Bocsi J, Rossler H, Schlykow V, Schneider P, Hambsch J. Low degree of activation of circulating neutrophils determined by flow cytometry during cardiac surgery with cardiopulmonary bypass. Cytometry 2001;46:41-9.
42. Ferrari G, Anderson BL, Stephens RM, Kaplan DR, Greene LA. Prevention of apoptotic neuronal death by GM1 ganglioside. Involvement of Trk neurotrophin receptors. J Biol Chem 1995;270:3074-80.
43. Argentino C, Sacchetti ML, Toni D, Savoini G, D'Arcangelo F, Erminio F, et al. GM1 ganglioside therapy in acute ischemic stroke. Italian Acute Stroke Study - Hemodilution + Drug. Stroke 1989;20:1143-9.
44. Grieco G, d'Hollosy M, Culliford AT, Jonas S. Evaluating neuroprotective agents for clinical anti-ischemic benefit using neurological and neuropsychological changes after cardiac surgery under cardiopulmonary bypass. Methodological strategies and results of a double-blind, placebo-controlled trial of GM1 ganglioside. Stroke 1996;27:858-74.
45. Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, Baskin DS, et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinalcord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med 1990;322:1405-11.
46. Sapolsky RM. Stress, Glucocorticoids, and Damage to the Nervous System: The Current State of Confusion. Stress 1996;1:1-19.
47. McIntosh LJ, Sapolsky RM. Glucocorticoids may enhance oxygen radical-mediated neurotoxicity. Neurotoxicology 1996;17:873-82.
48. Borsody MK, Coco ML. A hypothesis accounting for the inconsistent benefit of glucocorticoid therapy in closed head trauma. Med Hypotheses 2001;56:65-72.
49. Mathew JP, Grocott HP, Phillips-Bute B, Stafford-Smith M, Laskowitz DT, Rossignol D, et al. Lower endotoxin immunity predicts increased cognitive dysfunction in elderly patients after cardiac surgery. Stroke 2003;34:508-13.
50. Lanier WL. The prevention and treatment of cerebral ischemia. Can J Anaesth 1999;46(5 Pt 2):R46-56.
51. Mathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, Mazer CD, et al. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 2004;291:1720-9.
52. Stanley TO, Mackensen GB, Grocott HP, White WD, Blumental JA, Laskowitz DT, et al. The impact of postoperative atrial fibrillation on neurocognitive outcome after coronary artery bypass graft surgery. Anesth Analg 2002;94:290-5.
53. Amory DW, Grigore A, Amory JK, Gerhardt MA, White WD, Smith PK, et al. Neuroprotection is associated with beta-adrenergic receptor antagonists during cardiac surgery: evidence from 2,575 patients. J Cardiothorac Vasc Anesth 2002;16:270-7.
54. Wijeysundera DN, Naik JS, Beattie WS. Alpha-2 adrenergic agonists to prevent perioperative cardiovascular complications: a meta-analysis. Am J Med 2003;114:742-52.
55. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-36.
56. Kirino T. Ischemic tolerance. J Cereb Blood Flow Metab 2002;22:1283-96.
57. De Hert SG, Van der Linden PJ, Cromheecke S, Meeus R, Nelis A, Van Reeth V, et al. Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology 2004;101:299-310.
58. Julier K, da Silva R, Garcia C, Bestmann L, Frascarolo P, Zollinger A, et al. Preconditioning by sevoflurane decreases biochemical markers for myocardial and renal dysfunction in coronary artery bypass graft surgery: a double-blinded, placebo-controlled, multicenter study. Anesthesiology 2003;98:1315-27.
59. Sommerschild HT, Kirkeboen KA. Preconditioning - endogenous defense mechanisms of the heart. Acta Anaesthesiol Scand 2002;46:123-37.
60. Ardehali H. Role of the mitochondrial ATP-sensitive K+ channels in cardioprotection. Acta Biochim Pol 2004;51:379-90.
61. Kitagawa K, Matsumoto M, Tagaya M, Hata R, Ueda H, Niinobe M, et al. 'Ischemic tolerance' phenomenon found in the brain. Brain Res 1990;528:21-4.
62. Weih M, Kallenberg K, Bergk A, Dirnagl U, Harms L, Werecke KD, et al. Attenuated stroke severity after prodromal TIA: a role for ischemic tolerance in the brain? Stroke 1999;30:1851-4.
63. Moncayo J, de Freitas GR, Bogousslavsky J, Altieri M, van Melle G. Do transient ischemic attacks have a neuroprotective effect? Neurology 2000;54:2089-94.
64. Cope DK, Impastato WK, Cohen MV, Downey JM. Volatile anesthetics protect the ischemic rabbit myocardium from infarction. Anesthesiology 1997;86:699-709.
65. Zheng S, Zoo Z. Isoflurane preconditioning induces neuroprotection against ischemia via activation of P38 mitogen-activated protein kinases. Mol Pharmacol 2004;65:1172-80.
66. Zheng S, Zuo Z. Isoflurane preconditioning reduces purkinje cell death in an in vitro model of rat cerebellar ischemia. Neuroscience 2003;118:99-106.
67. Xiong L, Zheng Y, Wu M, Hou L, Zhu Z, Zhang X, et al. Preconditioning with isoflurane produces dose-dependent neuroprotection via activation of adenosine triphosphate-regulated potassium channels after focal cerebral ischemia in rats. Anesth Analg 2003;96:233-7.
68. Kapinya KJ, Lowl D, Futterer C, Maurer M, Waschke KF, Isaev NK, et al. Tolerance against ischemic neuronal injury can be induced by volatile anesthetics and is inducible NO synthase dependent. Stroke 2002;33:1889-98.
69. Blanck TJ, Haile M, Xu F, Zhang J, Heerdt P, Veselis RA, et al. Isoflurane pretreatment ameliorates postischemic neurologic dysfunction and preserves hippocampal Ca2+/calmodulin-dependent protein kinase in a canine cardiac arrest model. Anesthesiology 2000;93:1285-93.
70. Zhao P, Zuo Z. Isoflurane preconditioning induces neuroprotection that is inducible nitric oxide synthase-dependent in neonatal rats. Anesthesiology 2004;101:695-703.
71. Kapinya KJ, Prass K, Dimagl U. Isoflurane induced prolonged protection against cerebral ischemia in mice: a redox sensitive mechanism? Neuroreport 2002;13:1431-5.
72. Schultz JJ, Hsu AK, Gross GJ. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the heart. Circ Res 1996;78:1100-4.
73. Tomai F, Crea F, Gaspardone A, Versaci F, Ghini AS, Ferri C, et al. Effects of naloxone on myocardial ischemic preconditioning in humans. J. Am. Coll. Cardiol. 1999;33:1863-9
74. Zhang J, Gibney GT, Zhao P, Xia Y. Neuroprotective role of delta-opioid receptors in cortical neurons. Am J Physiol Cell Physiol 2002;282:C1225-34.
75. Lim YJ, Zheng S, Zuo Z. Morphine preconditions Purkinje cells against cell death under in vitro simulated ischemia-reperfusion conditions. Anesthesiology 2004;100:562-8.
76. Kakinohana M, Marsala M, Carter C, Davison JK, Yaksh TL. Neuraxial morphine may trigger transient motor dysfunction after a noninjurious interval of spinal cord ischemia: a clinical and experimental study. Anesthesiology 2003;98:862-70.
77. Faden AI, Jacobs TP, Holaday JW. Opiate antagonists improve neurologic recovery after spinal injury. Science 1981;11:493-4.
78. Corbett D, Nurse S. The problem of assessing effective neuroprotection in experimental cerebral ischemia. Prog Neurobiol 1998;54:531-48.
79. Gladstone DJ, Black SE, Hakim AM. Heart and Stroke Foundation of Ontario Centre of Excellence in Stroke Recovery. Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke 2002;33:2123-36.